))
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
1
Care Orchestration Optimizing Provider Capacity and Access to Care with Dr. Sonja Tarrago DexCare TRANSCRIPT
Dr. Sonja Tarrago, head of Physician Strategy and Engagement at DexCare, has created a care orchestration platform to help health systems improve patient access to care, direct patients to the proper care, and optimize provider capacity. DexCare solutions have enabled health systems to treat more patients with existing resources, increase new patie…
…
continue reading
1
Care Orchestration Optimizing Provider Capacity and Access to Care with Dr. Sonja Tarrago DexCare
19:44
19:44
Play later
Play later
Lists
Like
Liked
19:44
Dr. Sonja Tarrago, head of Physician Strategy and Engagement at DexCare, has created a care orchestration platform to help health systems improve patient access to care, direct patients to the proper care, and optimize provider capacity. DexCare solutions have enabled health systems to treat more patients with existing resources, increase new patie…
…
continue reading
1
Using AI to Tackle Demands of the Clinical Inbox Reducing Doctor Burnout with David Norris Affineon TRANSCRIPT
David Norris, Founder and CEO of Affineon Health Inc., recognizes the significant problem of provider burnout, which is primarily caused by the time doctors spend on administrative tasks rather than with the patient. Affineon's AI-powered solution aims to address this by automating the review of the provider's inbox and reducing their cognitive loa…
…
continue reading
1
Using AI to Tackle Demands of the Clinical Inbox Reducing Doctor Burnout with David Norris Affineon
20:48
20:48
Play later
Play later
Lists
Like
Liked
20:48
David Norris, Founder and CEO of Affineon Health Inc., recognizes the significant problem of provider burnout, which is primarily caused by the time doctors spend on administrative tasks rather than with the patient. Affineon's AI-powered solution aims to address this by automating the review of the provider's inbox and reducing their cognitive loa…
…
continue reading
1
Using Pulse Electric Field and Direct Tumor Injections to Target Advanced Cancers with Dr. Jason Williams The Williams Cancer Institute TRANSCRIPT
Dr. Jason Williams, President and Director of Interventional Oncology and Immunotherapy at the Williams Cancer Institute, uses a combination of Pulse Electric Field technology to ablate tumors and direct injection of immunotherapy drugs into the tumor to stimulate the immune system. This approach can be used in conjunction with traditional cancer t…
…
continue reading
1
Using Pulse Electric Field and Direct Tumor Injections to Target Advanced Cancers with Dr. Jason Williams The Williams Cancer Institute
17:41
17:41
Play later
Play later
Lists
Like
Liked
17:41
Dr. Jason Williams, President and Director of Interventional Oncology and Immunotherapy at the Williams Cancer Institute, uses a combination of Pulse Electric Field technology to ablate tumors and direct injection of immunotherapy drugs into the tumor to stimulate the immune system. This approach can be used in conjunction with traditional cancer t…
…
continue reading
Joel Stanley is the CEO of Ajna Biosciences, a company developing the next generation of botanical medicines. These full-spectrum drugs, derived from plants and fungi, are regulated and approved through the FDA, unlike dietary supplements. Lead drug candidates are targeting autism, generalized anxiety disorder, and PTSD. With expertise in cultivati…
…
continue reading
1
Next-Generation Full-Spectrum Botanical Medicines with Joel Stanley Ajna Biosciences
22:42
22:42
Play later
Play later
Lists
Like
Liked
22:42
Joel Stanley is the CEO of Ajna Biosciences, a company developing the next generation of botanical medicines. These full-spectrum drugs, derived from plants and fungi, are regulated and approved through the FDA, unlike dietary supplements. Lead drug candidates are targeting autism, generalized anxiety disorder, and PTSD. With expertise in cultivati…
…
continue reading
1
Role for AI-Enhanced Screening in Early Detection of Breast Cancer with Dana Brown iCAD TRANSCRIPT
Dana Brown serves as President, CEO, and Chairman of the Board at iCAD Inc., which has developed a next-generation approach that leverages advancements in AI and imaging technology to improve the accuracy and efficiency of breast cancer screening. This technology can help reduce unnecessary biopsies and additional tests while more accurately identi…
…
continue reading
1
Role for AI-Enhanced Screening in Early Detection of Breast Cancer with Dana Brown iCAD
19:00
19:00
Play later
Play later
Lists
Like
Liked
19:00
Dana Brown serves as President, CEO, and Chairman of the Board at iCAD Inc., which has developed a next-generation approach that leverages advancements in AI and imaging technology to improve the accuracy and efficiency of breast cancer screening. This technology can help reduce unnecessary biopsies and additional tests while more accurately identi…
…
continue reading
1
Early Detection of Alzheimer’s Protein Biomarker with Home Blood Test with Dr. Rany Aburashed Neurogen Biomarking TRANSCRIPT
Dr. Rany Aburashed, CEO and Founder of Neurogen Biomarking, is using a blood-based biomarker looking at p-tau 217 to detect early signs of Alzheimer's disease, up to 8-10 years before the onset of clinical symptoms. The company has built an ecosystem to provide patients with a comprehensive health assessment with an at-home blood test, cognitive te…
…
continue reading
1
Early Detection of Alzheimer’s Protein Biomarker with Home Blood Test with Dr. Rany Aburashed Neurogen Biomarking
26:41
26:41
Play later
Play later
Lists
Like
Liked
26:41
Dr. Rany Aburashed, CEO and Founder of Neurogen Biomarking, is using a blood-based biomarker looking at p-tau 217 to detect early signs of Alzheimer's disease, up to 8-10 years before the onset of clinical symptoms. The company has built an ecosystem to provide patients with a comprehensive health assessment with an at-home blood test, cognitive te…
…
continue reading
1
Impact of Integrating AI into Behavioral Health Workflow and Patient Engagement with Ram Krishnan Valant TRANSCRIPT
Ram Krishnan, CEO of Valant, uses AI to make mental health care more accessible through their practice management and patient engagement platforms designed specifically for mental health providers. AI is applied to improve administrative efficiency, address billing and compliance, and drive successful patient outcomes. New solutions are needed due …
…
continue reading
1
Impact of Integrating AI into Behavioral Health Workflow and Patient Engagement with Ram Krishnan Valant
21:11
21:11
Play later
Play later
Lists
Like
Liked
21:11
Ram Krishnan, CEO of Valant, uses AI to make mental health care more accessible through their practice management and patient engagement platforms designed specifically for mental health providers. AI is applied to improve administrative efficiency, address billing and compliance, and drive successful patient outcomes. New solutions are needed due …
…
continue reading
1
Organ Preservation Technology Transforming Organ Transplantation with Jaya Tiwari XVIVO TRANSCRIPT
Jaya Tiwari, Senior Vice President of Clinical and Regulatory Affairs at XVIVO, which is focused on improving organ preservation for transplantation. Current organ preservation methods using ice coolers limit the time and distance organs can be transported. XVIVO's perfusion technology can significantly extend the preservation time of hearts, kidne…
…
continue reading
1
Organ Preservation Technology Transforming Organ Transplantation with Jaya Tiwari XVIVO
17:38
17:38
Play later
Play later
Lists
Like
Liked
17:38
Jaya Tiwari, Senior Vice President of Clinical and Regulatory Affairs at XVIVO, which is focused on improving organ preservation for transplantation. Current organ preservation methods using ice coolers limit the time and distance organs can be transported. XVIVO's perfusion technology can significantly extend the preservation time of hearts, kidne…
…
continue reading
1
Interoperability Breaks Down Healthcare Silos to Facilitate Value-Based Care with Brian Drozdowicz PointClickCare TRANSCRIPT
Brian Drozdowicz, Senior VP and General Manager for Acute and Payer at PointClickCare, provides a platform using predictive analytics and AI for data sharing and collaboration across healthcare stakeholders. Interoperability has been an ongoing challenge due to the lack of standards and clear governance to support data sharing. The shift to value-b…
…
continue reading
1
Interoperability Breaks Down Healthcare Silos to Facilitate Value-Based Care with Brian Drozdowicz PointClickCare
18:40
18:40
Play later
Play later
Lists
Like
Liked
18:40
Brian Drozdowicz, Senior VP and General Manager for Acute and Payer at PointClickCare, provides a platform using predictive analytics and AI for data sharing and collaboration across healthcare stakeholders. Interoperability has been an ongoing challenge due to the lack of standards and clear governance to support data sharing. The shift to value-b…
…
continue reading
1
Real-Time Nudges to Physicians Help Reduce Clinical Waste in Hospitals with G. T. LaBorde IllumiCare TRANSCRIPT
G.T. LaBorde, CEO and Co-Founder of IllumiCare, focuses on reducing hospital clinical waste. Doctors often make decisions about tests, medications, and procedures without knowing the actual cost to the hospital and the patient. The IllumiCare platform aims to nudge doctors to make cost-effective decisions without compromising the quality of patient…
…
continue reading
1
Real-Time Nudges to Physicians Help Reduce Clinical Waste in Hospitals with G. T. LaBorde IllumiCare
20:57
20:57
Play later
Play later
Lists
Like
Liked
20:57
G.T. LaBorde, CEO and Co-Founder of IllumiCare, focuses on reducing hospital clinical waste. Doctors often make decisions about tests, medications, and procedures without knowing the actual cost to the hospital and the patient. The IllumiCare platform aims to nudge doctors to make cost-effective decisions without compromising the quality of patient…
…
continue reading
1
Precision Allergy Diagnostics Based on Molecular Allergy Testing with Gary Falcetano Thermo Fisher Scientific TRANSCRIPT
Gary Falcetano, Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, is a leader in allergy and autoimmune diagnostics, providing specific IgE tests and the instruments to run them. Accurately diagnosing allergies can be challenging, but specific IgE testing can help confirm the underlying causes by looking at individual allergen com…
…
continue reading
1
Precision Allergy Diagnostics Based on Molecular Allergy Testing with Gary Falcetano Thermo Fisher Scientific
18:55
18:55
Play later
Play later
Lists
Like
Liked
18:55
Gary Falcetano, Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, is a leader in allergy and autoimmune diagnostics, providing specific IgE tests and the instruments to run them. Accurately diagnosing allergies can be challenging, but specific IgE testing can help confirm the underlying causes by looking at individual allergen com…
…
continue reading
1
Human-Centric AgeTech Innovations Support Ecosystem for Aging Care with Chia-Lin Simmons LogicMark TRANSCRIPT
Chia-Lin Simmons, CEO of LogicMark, is developing technology solutions to help seniors age independently and safely. Their AgeTech ecosystem addresses the requirements and comfort levels of the diverse aging population and provides predictive technology to identify potential health issues and emergencies. The key is keeping a human-centric approach…
…
continue reading
1
Human-Centric AgeTech Innovations Support Ecosystem for Aging Care with Chia-Lin Simmons LogicMark
23:46
23:46
Play later
Play later
Lists
Like
Liked
23:46
Chia-Lin Simmons, CEO of LogicMark, is developing technology solutions to help seniors age independently and safely. Their AgeTech ecosystem addresses the requirements and comfort levels of the diverse aging population and provides predictive technology to identify potential health issues and emergencies. The key is keeping a human-centric approach…
…
continue reading
1
AI-Powered Antibody Drug Discovery for Obesity and Cardiometabolic Diseases with Martin Brenner iBio TRANSCRIPT
Martin Brenner, CEO and Chief Scientific Officer of iBio, is focused on the untapped potential of therapeutic antibodies for obesity and cardiometabolic diseases. Leveraging AI and machine learning, iBio is streamlining the antibody discovery and optimization process and addressing the need for more complex antibody mechanisms of action. Their lead…
…
continue reading
